THE LATEST FROM FOCAL POINT RESEARCH

Top 10 Cosmetic Notification Form Errors (and How to Avoid Them)

Top 10 Cosmetic Notification Form Errors (and How to Avoid Them)

All cosmetic products that are sold in Canada must be notified to Health Canada in compliance with the Cosmetic Regulations by submitting a Cosmetic Notification Form (CNF). A product is considered a cosmetic if it meets the following definition:

  • Serves the purpose of cleansing, moisturizing, lubricating, perfuming, or cosmetically altering the hair, skin, teeth, complexion of humans or animals
  • Contains a substance of mixture of substances that come into contact with the body, especially the skin, hair, nails, and teeth.
  • There is no representation or claims of therapeutic effects such as disease/disorder prevention or treatment.
  • It does not contain ingredients with a primary therapeutic purpose.
  Some products applied to the oral, nasal, or vaginal cavities may be considered cosmetics. Products applied directly into the eyes (e.g. eye drops) and articles such as brushes, razors and applicators are not considered cosmetics. Cosmetics must be notified by the individual or firm that is responsible for the product in Canada, or a party that is authorised on their behalf. This can be the manufacturer, distributor, or importer.

Resolving Common Cosmetic Notification Form Errors

Errors on a Cosmetic Notification Form can result in delays in processing or rejection of the form.  The [...]

Learn more

Batch vs. Continuous Manufacturing- Which One is Right for You?

Continuous Manufacturing Recent advances in manufacturing technology have encouraged many companies to make the switch from batch to continuous manufacturing. The transition has huge potential in the pharmaceutical industry. How do you know if it is the right decision for you? Here are the advantages and drawbacks of each system to help you decide which one is best for your company.  

Batch Manufacturing

Batch manufacturing is performed using several discrete steps. After each step, offline quality tests are performed on samples. Batch manufacturing can take up to several months for finished product to be output. Batch manufacturing is often the preferred processing system for small quantity/high quality products such as perfumes and active pharmaceutical ingredients.

Advantages:

  • Regulatory: traditional manufacturing methods do not impact speed of product approval.
  • Start up cost: if you are new to manufacturing, equipment for batch manufacturing is much lower in cost than for continuous manufacturing and can even be found second hand.
  • Waste: batch production reduces the quantity of surplus product that goes to waste if retailers cancel future orders due to a decrease in market demand.

Drawbacks:

  • Time: material may be shipped to different facilities for different steps. Degradation of active ingredients [...]

Learn more

March for Cosmetic Science: Why Consumer Perceptions Need to Stop Influencing Ingredient Restrictions- Our View

March for Cosmetic Science: Why Consumer Perceptions Need to Stop Influencing Ingredient Restrictions- Our View

In April, hundreds of thousands of people around the globe took part in over 600 rallies that were part of the “March for Science”. While the demonstrations specifically targeted issues such as climate change and concerns that science based policy is being rejected, they highlighted the underlying issue of distrust and ineffective communication between the scientific community, the government, and consumers.

The Cosmetics Industry

This has long been a problem in the cosmetics industry. Consumers have become more concerned about safety, sustainability, ingredient sourcing and processing methods in evaluating the products they wish to use. Sadly, many consumers are too often basing their perception of the safety of cosmetic ingredients on junk science or information with no relevance or context. They often cite a handful of dubious papers and studies that have been largely rejected by the wide scientific community They ask, “Does the ingredient have a chemical sounding name?” and “Is the ingredient synthetically produced?” instead of valid, scientific questions like, “What do independent third party trials on this ingredient’s safety show?”. This has caused consumers to exert enormous influence on public perception and on retailers to alter their house brand formulations, or restrict their listed products to companies [...]

Learn more

CVS Corporate Restructuring Brings Changes for Dietary Supplements Suppliers

CVS Corporate Restructuring Brings Changes for Dietary Supplements Suppliers

CVS Pharmacy recently announced a major restructuring of its stores and product offerings, with an emphasis on dietary supplements and cosmetics. CVS owns and operates over 9,700 pharmacies across the United States.

Changes to Dietary Supplements & Food Products

The company is establishing new standards for dietary supplements, including third party testing of ingredients for vitamins and supplements, as well as full product testing for certain ingredients of concern. The changes are expected to be fully implemented by 2019 and will affect over 100 supplier partners and 800 products including vitamins, supplements, weight control products, protein powders, and energy shots/powders. CVS also aims to have healthy products make up 50% of overall food offerings.

Changes to Cosmetic Products

CVS is also making changes to their own personal care and cosmetics brands. By the end of 2019, ingredients that consumers perceive as harmful will be removed from formulations. These include parabens, phthalates, and some formaldehyde donors. The company already makes a list of ingredients classified as “restricted chemicals” under The California Safe Cosmetics Act and Prop 65 available on its website. The change [...]

Learn more

FDA Labelling Changes for Children’s Use of Codeine and Tramadol Products

FDA Labelling Changes for Children’s Use of Codeine and Tramadol Products

Codeine and Tramadol are narcotics frequently included in medications to treat pain or cough. A safety review launched by the FDA in 2015 found that the drugs have serious risks for patients under the age of 12, including slowed or difficult breathing and death. They also carry a risk for patients up to age 18 years old who have breathing troubles. Children and some adults break down codeine and tramadol faster than normal, causing the level of opioids in these patients to rise too high and too quickly. The FDA reviewed adverse event reports submitted between January 1969 and May 2015. It identified 64 cases of serious breathing problems, including 24 deaths, with codeine-containing medicines in children younger than 18 years. Labelling requirements for prescription Codeine and Tramadol products have been updated to include the following:

  • contraindications for the use of codeine or tramadol in all children younger than 12 years
  • warnings about their use in children 12-18 years of age with certain medical conditions such as obesity, obstructive sleep apnea, or severe lung disease, which may increase the risk of serious breathing problems
  • stronger warnings recommending against their [...]

Learn more